Tapewire

Nasdaq · USD

RARE

Ultragenyx Pharmaceutical Inc.

Export transactions ↓
Tapewire entity
4337
SEC CIK
0001515673
Parsed reports
478

Last 12 months

Inside the activity.

0 purchase rows · 27 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202601
Feb 202601
Mar 2026011
Apr 202601
May 202603
Jun 202603
Jul 202601
Aug 202602
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2025 Filed Mar 3, 2025 18:58 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
GrantCommon Stock 14,494 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-030639 · ownership.xml · nonDerivative · entry 3

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,690

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

F3 · balance_after: Includes 205 shares acquired on October 31, 2024 under the Company's Amended and Restated Employee Stock Purchase Plan

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:19 UTC GrantCommon Stock 18,443 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032802 · ownership.xml · nonDerivative · entry 1

Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,266

F1 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2025 upon certification of the performance metric.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:10 UTC
KAKKIS EMIL DDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 78,448 $0.00 Strike: $42.92 $0.00
Disclosure

SEC source: 0000950170-25-032779 · ownership.xml · derivative · entry 5

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 78,448

Underlying: Common Stock · 78,448 shares

Expires 2035-03-01

F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:10 UTC
KAKKIS EMIL DDirector · President & CEO
GrantCommon Stock 107,292 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032779 · ownership.xml · nonDerivative · entry 2

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 715,165

F2 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2025 upon certification of the performance metric.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:10 UTC
KAKKIS EMIL DDirector · President & CEO
GrantCommon Stock 43,268 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032779 · ownership.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 607,873

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:18 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
GrantCommon Stock 18,443 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032798 · ownership.xml · nonDerivative · entry 1

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,133

F1 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2025 upon certification of the performance metric.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:16 UTC
Crombez EricEVP and Chief Medical Officer
GrantStock Ooption (Right to Buy) · Derivative 30,246 $0.00 Strike: $42.92 $0.00
Disclosure

SEC source: 0000950170-25-032794 · ownership.xml · derivative · entry 4

Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,246

Underlying: Common Stock · 30,246 shares

Expires 2035-03-01

F7 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:16 UTC
Crombez EricEVP and Chief Medical Officer
GrantCommon Stock 14,971 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032794 · ownership.xml · nonDerivative · entry 2

Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,215

F2 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2025 upon certification of the performance metric.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:16 UTC
Crombez EricEVP and Chief Medical Officer
GrantCommon Stock 16,813 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032794 · ownership.xml · nonDerivative · entry 1

Crombez Eric · CIK 0001653052 · EVP and Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,244

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:12 UTC GrantStock Option (Right to Buy) · Derivative 26,074 $0.00 Strike: $42.92 $0.00
Disclosure

SEC source: 0000950170-25-032785 · ownership.xml · derivative · entry 5

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,074

Underlying: Commmon Stock · 26,074 shares

Expires 2035-03-01

F8 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:12 UTC GrantCommon Stock 18,443 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032785 · ownership.xml · nonDerivative · entry 2

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,205

F2 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2025 upon certification of the performance metric.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:12 UTC GrantCommon Stock 14,494 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032785 · ownership.xml · nonDerivative · entry 1

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,762

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:06 UTC
Harris ErikEVP & Chief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 30,246 $0.00 Strike: $42.92 $0.00
Disclosure

SEC source: 0000950170-25-032773 · ownership.xml · derivative · entry 4

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,246

Underlying: Common Stock · 30,246 shares

Expires 2035-03-01

F7 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:06 UTC
Harris ErikEVP & Chief Commercial Officer
GrantCommon Stock 18,443 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032773 · ownership.xml · nonDerivative · entry 2

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,419

F2 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2025 upon certification of the performance metric.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:06 UTC
Harris ErikEVP & Chief Commercial Officer
GrantCommon Stock 16,813 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032773 · ownership.xml · nonDerivative · entry 1

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,976

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:02 UTC GrantStock Option (Right to Buy) · Derivative 26,074 $0.00 Strike: $42.92 $0.00
Disclosure

SEC source: 0000950170-25-032767 · ownership.xml · derivative · entry 4

Huang Dennis Karl · CIK 0001641217 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,074

Underlying: Common Stock · 26,074 shares

Expires 2035-03-01

F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:02 UTC GrantCommon Stock 18,443 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032767 · ownership.xml · nonDerivative · entry 2

Huang Dennis Karl · CIK 0001641217 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,939

F2 · shares: Represents shares of common stock which previously granted performance stock units were converted on March 1, 2025 upon certification of the performance metric.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:02 UTC GrantCommon Stock 14,494 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032767 · ownership.xml · nonDerivative · entry 1

Huang Dennis Karl · CIK 0001641217 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,496

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:00 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 5,632 $0.00 Strike: $42.92 $0.00
Disclosure

SEC source: 0000950170-25-032764 · ownership.xml · derivative · entry 4

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,632

Underlying: Common Stock · 5,632 shares

Expires 2035-03-01

F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 01:00 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
GrantCommon Stock 9,392 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032764 · ownership.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,232

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date

Read SEC document
March 01, 2025 Filed Mar 5, 2025 00:56 UTC
Horn HowardChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 28,160 $0.00 Strike: $42.92 $0.00
Disclosure

SEC source: 0000950170-25-032750 · ownership.xml · derivative · entry 2

Horn Howard · CIK 0001786335 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,160

Underlying: Common Stock · 28,160 shares

Expires 2035-03-01

F3 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2025 Filed Mar 5, 2025 00:56 UTC
Horn HowardChief Financial Officer
GrantCommon Stock 15,653 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-032750 · ownership.xml · nonDerivative · entry 1

Horn Howard · CIK 0001786335 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,954

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 01:10 UTC
KAKKIS EMIL DDirector · President & CEO
SaleCommon Stock 25,000 $42.48 $1,062,000.00
Disclosure

SEC source: 0000950170-25-032779 · ownership.xml · nonDerivative · entry 4

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009

Disclosed balance after: 2,158,985

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.89 to $42.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 27, 2025 Filed Mar 3, 2025 18:58 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
SaleCommon Stock 760 $42.75 $32,490.00
Disclosure

SEC source: 0000950170-25-030639 · ownership.xml · nonDerivative · entry 2

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,991

Read SEC document
February 27, 2025 Filed Mar 3, 2025 18:58 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
SaleCommon Stock 2,230 $42.93 $95,733.90
Disclosure

SEC source: 0000950170-25-030639 · ownership.xml · nonDerivative · entry 1

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,751

Read SEC document
December 30, 2024 Filed Dec 31, 2024 19:05 UTC
KAKKIS EMIL DDirector · President & CEO
SaleCommon Stock 11,727 $42.23 $495,231.21
Disclosure

SEC source: 0000950170-24-141485 · ownership.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009

Disclosed balance after: 2,183,985

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.58 to $43.02 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 23:44 UTC
KAKKIS EMIL DDirector · President & CEO
SaleCommon Stock 8,273 $50.00 $413,650.00
Disclosure

SEC source: 0000950170-24-135521 · ownership.xml · nonDerivative · entry 2

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009

Disclosed balance after: 2,195,712

Read SEC document
December 10, 2024 Filed Dec 11, 2024 23:47 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
GiftCommon Stock 648 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-135525 · ownership.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,840

F1 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

F2 · balance_after: Includes 237 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on October 31, 2024.

Read SEC document
December 09, 2024 Filed Dec 11, 2024 23:44 UTC
KAKKIS EMIL DDirector · President & CEO
GiftCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-135521 · ownership.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009

Disclosed balance after: 2,203,985

Read SEC document
October 10, 2024 Filed Oct 11, 2024 20:48 UTC
Horn HowardChief Financial Officer
SaleCommon Stock 7,465 $52.76 $393,853.40
Disclosure

SEC source: 0000950170-24-114378 · ownership.xml · nonDerivative · entry 1

Horn Howard · CIK 0001786335 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,301

F1 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
September 16, 2024 Filed Sep 18, 2024 17:03 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
GrantCommon Stock 700 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-107677 · ownership.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,251

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 15:53 UTC
KAKKIS EMIL DDirector · President & CEO
SaleCommon Stock 20,000 $55.85 $1,117,000.00
Disclosure

SEC source: 0000950170-24-103811 · ownership.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · See FN

Disclosed balance after: 2,223,985

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.02 to $57.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009

Read SEC document
September 03, 2024 Filed Sep 5, 2024 15:50 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
SaleCommon Stock 91 $56.19 $5,113.29
Disclosure

SEC source: 0000950170-24-103807 · ownership.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,551

F1 · shares: Represents shares sold to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes 276 shares acquired under the Company's Amended and Restated 2014 Employee Stock Purchase Plan on April 30, 2024

F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
August 06, 2024 Filed Aug 7, 2024 18:48 UTC
KAKKIS EMIL DDirector · President & CEO
SaleCommon Stock 20,000 $50.17 $1,003,400.00
Disclosure

SEC source: 0000950170-24-092608 · ownership.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Indirect · See FN

Disclosed balance after: 2,243,985

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009

Read SEC document
July 02, 2024 Filed Jul 3, 2024 18:07 UTC SaleCommon Stock 584 $40.98 $23,932.32
Disclosure

SEC source: 0000950170-24-081302 · ownership.xml · nonDerivative · entry 1

Sanders Corazon (Corsee) D. · CIK 0001796536 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,009

Read SEC document
June 18, 2024 Filed Jun 20, 2024 14:23 UTC
Ray AmritDirector
GrantStock Option (Right to Buy) · Derivative 9,900 $0.00 Strike: $37.42 $0.00
Disclosure

SEC source: 0000950170-24-075486 · ownership.xml · derivative · entry 2

Ray Amrit · CIK 0001924797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,900

Underlying: Common Stock · 9,900 shares

Expires 2034-06-18

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 14:23 UTC
Ray AmritDirector
GrantCommon Stock 5,345 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-075486 · ownership.xml · nonDerivative · entry 1

Ray Amrit · CIK 0001924797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,625

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 18:25 UTC GrantStock Option (Right to Buy) · Derivative 9,900 $0.00 Strike: $37.42 $0.00
Disclosure

SEC source: 0000950170-24-075488 · ownership.xml · derivative · entry 2

WELCH DANIEL G · CIK 0001206199 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,900

Underlying: Common Stock · 9,900 shares

Expires 2034-06-18

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 18:25 UTC GrantCommon Stock 5,345 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-075488 · ownership.xml · nonDerivative · entry 1

WELCH DANIEL G · CIK 0001206199 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,950

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 18:29 UTC GrantStock Option (Right to Buy) · Derivative 9,900 $0.00 Strike: $37.42 $0.00
Disclosure

SEC source: 0000950170-24-075491 · ownership.xml · derivative · entry 2

Dunsire Deborah · CIK 0001332764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,900

Underlying: Common Stock · 9,900 shares

Expires 2034-06-18

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 18:29 UTC GrantCommon Stock 5,345 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-075491 · ownership.xml · nonDerivative · entry 1

Dunsire Deborah · CIK 0001332764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,075

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 14:24 UTC GrantStock Option (Right to Buy) · Derivative 9,900 $0.00 Strike: $37.42 $0.00
Disclosure

SEC source: 0000950170-24-075487 · ownership.xml · derivative · entry 2

NARACHI MICHAEL · CIK 0001380022 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,900

Underlying: Common Stock · 9,900 shares

Expires 2034-06-18

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 14:24 UTC GrantCommon Stock 5,345 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-075487 · ownership.xml · nonDerivative · entry 1

NARACHI MICHAEL · CIK 0001380022 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,950

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 18:26 UTC GrantStock Option (Right to Buy) · Derivative 9,900 $0.00 Strike: $37.42 $0.00
Disclosure

SEC source: 0000950170-24-075489 · ownership.xml · derivative · entry 2

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,900

Underlying: Common Stock · 9,900 shares

Expires 2034-06-18

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 18:26 UTC GrantCommon Stock 5,345 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-075489 · ownership.xml · nonDerivative · entry 1

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,205

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 18:22 UTC GrantStock Option (Right to Buy) · Derivative 9,900 $0.00 Strike: $37.42 $0.00
Disclosure

SEC source: 0000950170-24-075485 · ownership.xml · derivative · entry 2

Sanders Corazon (Corsee) D. · CIK 0001796536 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,900

Underlying: Common Stock · 9,900 shares

Expires 2034-06-18

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 18:22 UTC GrantCommon Stock 5,345 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-075485 · ownership.xml · nonDerivative · entry 1

Sanders Corazon (Corsee) D. · CIK 0001796536 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,593

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 18:22 UTC GrantStock Option (Right to Buy) · Derivative 9,900 $0.00 Strike: $37.42 $0.00
Disclosure

SEC source: 0000950170-24-075483 · ownership.xml · derivative · entry 2

SULIMAN SHEHNAAZ · CIK 0001713070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,900

Underlying: Common Stock · 9,900 shares

Expires 2034-06-18

F2 · derivative.exercise_date: The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 18:22 UTC GrantCommon Stock 5,345 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-075483 · ownership.xml · nonDerivative · entry 1

SULIMAN SHEHNAAZ · CIK 0001713070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,200

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025.

Read SEC document
June 12, 2024 Filed Jun 12, 2024 23:47 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
SaleCommon Stock 9,806 $45.00 $441,270.00
Disclosure

SEC source: 0000950170-24-072621 · ownership.xml · nonDerivative · entry 1

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,981

F1 · balance_after: Includes 447 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on April 30, 2024.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.